The initiation and persistence of multiple organ pathologies, which may occur during life, are intimately associated with acute and chronic dysregulatory metabolic processes. Multiple organ pathologies may also be functionally associated with initiating traumatic events leading to a chronic state of proinflammatory cellular insults with resultant prolonged debilitation and negative quality of life. Along these lines, a large body of preclinical and clinical literature has established that acute and chronic perturbations of the functional coupling of vascular endothelial, immune, and neural cell types represent major contributory factors to the initiation and persistence of pathological states [1]. Furthermore, metabolic rundown in each of these cell types is intimately linked to primary functional deficits in their endosymbiont mitochondria. Mechanistically, dysregulation of mitochondrial respiration leads to impairment of intermediary energy metabolism, ATP production, and insufficient buffering of harmful reactive oxygen species [2]. Resultant damage to mtDNA has profound effects on mitochondrial rescue and biogenesis upon physiological demand. Similar criteria may relate to the elucidation of key cellular mechanisms underlying normal and premature ageing. In light of the above, common regulatory events and their potential dysregulation in neuroimmune-vascular disorders are listed below.
Endothelia serve as major cellular conduits mediating oxygen and carbon dioxide exchange, nutrient transport, and autonomic tone in the peripheral and CNS vasculature. Notably, functional deficiencies in vascular endothelia has been documented in variety of human metabolic disorders including diabetes and cardiovascular disease [3–19]. Mitochondria-associated oxidative stress has been proposed as a major contributing factor to the severity of endothelial malfunction in these same metabolic disorders [3–19].
The immune system serves to defend the body from external and internal threats and keep multiple organ systems in metabolic homeostasis. Ongoing host-defense mechanisms utilize complementary regulatory processes to perform existential functions ranging from antibody production to immune surveillance and phagocytosis. Functional immunodeficiencies including perturbations in neuroimmune and vascular endothelial cellular coupling has been observed in multiple human pathological disorders [1, 20–34]. It has also become apparent that dysregulation of mitochondrial function mediated by disruption of constitutive nitric oxide signaling mechanisms represents a strong contributing factor in neuroimmune/vascular endothelial-coupled cellular pathologies [1, 20–34].
The nervous system serves an existential integrative capacity for functional entrainment of multiple organ function. Within the central and peripheral nervous systems, sensory, motor, and intrinsic neurons employ a wide variety of chemical and gaseous messenger molecules. Accordingly, central and peripheral neurons integrate sensory input and coordinated motor responses via immediate and long lasting chemical messengers. As stated above, vital neuroimmune/vascular endothelial-coupled metabolic regulation modulates homeostasis of cellular energy production in multiple organ systems. Its dysregulation is intimately associated with a variety of acute and chronic pathophysiological disorders [35–55].
Multiple organ pathologies are intimately associated with acute and chronic dysregulation of metabolic processes responsible for normal neuroimmune/vascular endothelial coupling events. An in depth analysis of perturbation of common regulatory events underlying normal mitochondrial function will elucidate convergent mechanisms leading to the initiation and persistence of multiple organ pathologies in human metabolic disorders.
References
- 1.Stefano GB, Esch T, Bilfinger TV, Kream RM. Proinflammation and preconditioning protection are part of a common nitric oxide mediated process. Med Sci Monit. 2010;16:RA125–30. [PubMed] [Google Scholar]
- 2.Kream RM, Stefano GB. Endogenous morphine and nitric oxide coupled regulation of mitochondrial processes. Med Sci Monit. 2009;15:RA263–8. [PubMed] [Google Scholar]
- 3.Bismuth J, Chai H, Lin PH, Yao Q, Chen C. Lactosylceramide causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells. Med Sci Monit. 2009;15:BR270–4. [PMC free article] [PubMed] [Google Scholar]
- 4.Hamzaoui K, Bouali E, Ghorbel I, Khanfir M, Houman H, Hamzaoui A. Expression of Th-17 and RORgammat mRNA in Behcet's Disease. Med Sci Monit. 2011;17:CR227–34. doi: 10.12659/MSM.881720. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Li W, Yang SY, Hu ZF, Winslet MC, Wang W, Seifalian AM. Growth factors enhance endothelial progenitor cell proliferation under high-glucose conditions. Med Sci Monit. 2009;15:BR357–63. [PubMed] [Google Scholar]
- 6.Misra MK, Sarwat M, Bhakuni P, Tuteja R, Tuteja N. Oxidative stress and ischemic myocardial syndromes. Med Sci Monit. 2009;15:RA209–19. [PubMed] [Google Scholar]
- 7.Suminska-Jasinska K, Polubinska A, Ciszewicz M, Mikstacki A, Antoniewicz A, Breborowicz A. Sulodexide reduces senescence-related changes in human endothelial cells. Med Sci Monit. 2011;17:CR222–6. doi: 10.12659/MSM.881719. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Voisard R, Munder U, von ML, Baur R, Hombach V. Direct inhibitory effects of Ganciclovir on ICAM-1 expression and proliferation in human coronary vascular cells (SI/MPL-ratio: >1) Med Sci Monit. 2011;17:I1–6. doi: 10.12659/MSM.881310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Voisard R, Ramiz E, Baur R, et al. Pulsed perfusion in a venous human organ culture model with a Windkessel function (pulsed perfusion venous HOC-model) Med Sci Monit. 2010;16:CR523–9. [PubMed] [Google Scholar]
- 10.Xiao-Yun X, Zhuo-Xiong C, Min-Xiang L, et al. Ceramide mediates inhibition of the AKT/eNOS signaling pathway by palmitate in human vascular endothelial cells. Med Sci Monit. 2009;15:BR254–61. [PubMed] [Google Scholar]
- 11.Xiao-Yun X, Zhao-Hui M, Ke C, Hong-Hui H, Yan-Hong X. Glucagon-like peptide-1 improves proliferation and differentiation of endothelial progenitor cells via upregulating VEGF generation. Med Sci Monit. 2011;17:BR35–41. doi: 10.12659/MSM.881383. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Yang H, Zhang L, Weakley SM, Lin PH, Yao Q, Chen C. Transforming growth factor-beta increases the expression of vascular smooth muscle cell markers in human multi-lineage progenitor cells. Med Sci Monit. 2011;17:BR55–61. doi: 10.12659/MSM.881439. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Zhang D, Wang W, Zhou D, et al. Ghrelin inhibits apoptosis induced by palmitate in rat aortic endothelial cells. Med Sci Monit. 2010;16:BR396–403. [PubMed] [Google Scholar]
- 14.Bissinger A, Grycewicz T, Grabowicz W, Lubinski A. Endothelial function and left ventricular remodeling in diabetic and non-diabetic patients after acute coronary syndrome. Med Sci Monit. 2011;17:CR73–7. doi: 10.12659/MSM.881390. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Cable DG, Celotto AC, Evora PR, Schaff HV. Asymmetric dimethylarginine endogenous inhibition of nitric oxide synthase causes differential vasculature effects. Med Sci Monit. 2009;15:BR248–53. [PubMed] [Google Scholar]
- 16.Chrusciel P, Goch A, Banach M, Mikhailidis DP, Rysz J, Goch JH. Circadian changes in the hemostatic system in healthy men and patients with cardiovascular diseases. Med Sci Monit. 2009;15:RA203–8. doi: 10.12659/msm.878203. [DOI] [PubMed] [Google Scholar]
- 17.Krejca M, Plewka A, Szmagala P, et al. Outside stenting of the vein graft decreases VEGF-A expression and induces significant down-regulation of VEGFR-1 in the intimal and medial layers after the re-endothelialization period. Med Sci Monit. 2010;16:BR89–96. [PubMed] [Google Scholar]
- 18.Li Y, Wu Y, Wang Z, Zhang XH, Wu WK. Fasudil attenuates lipopolysaccharide-induced acute lung injury in mice through the Rho/Rho kinase pathway. Med Sci Monit. 2010;16:BR112–8. [PubMed] [Google Scholar]
- 19.Michalska M, Gluba A, Mikhailidis DP, et al. The role of polyphenols in cardiovascular disease. Med Sci Monit. 2010;16:RA110–9. [PubMed] [Google Scholar]
- 20.Chalubinski M, Broncel M. Influence of statins on effector and regulatory immune mechanisms and their potential clinical relevance in treating autoimmune disorders. Med Sci Monit. 2010;16:RA245–51. [PubMed] [Google Scholar]
- 21.Fang Y, Hu J. Toll-like receptor and its roles in myocardial ischemic/reperfusion injury. Med Sci Monit. 2011;17:RA100–9. doi: 10.12659/MSM.881709. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Kiykim AA, Genctoy G, Horoz M, et al. Nephrotic-range proteinuria with small glomerular fibrillary deposits in a patient on diphenylhydantoin treatment. Med Sci Monit. 2009;15:CS132–4. [PubMed] [Google Scholar]
- 23.Lorenson L, DeSantis A, Mannath T, Mirza F, Weeks BS. The antimicrobial and phagocytic defense mechanisms of the terrestrial gastropod Lehmannia nyctelia against Escherichia coli and Staphylococcus aureus. Med Sci Monit. 2010;16:BR339–46. [PubMed] [Google Scholar]
- 24.Mravec B, Ondicova K, Valaskova Z, Gidron Y, Hulin I. Neurobiological principles in the etiopathogenesis of disease: when diseases have a head. Med Sci Monit. 2009;15:RA6–16. [PubMed] [Google Scholar]
- 25.Rigante D. Autoinflammatory syndromes behind the scenes of recurrent fevers in children. Med Sci Monit. 2009;15:RA179–87. [PubMed] [Google Scholar]
- 26.Selim AA. Osteoactivin bioinformatic analysis: prediction of novel functions, structural features, and modes of action. Med Sci Monit. 2009;15:MT19–33. [PubMed] [Google Scholar]
- 27.Serwacka A, Protaziuk T, Zagozda M, et al. Lack of effect of the CD14 promoter gene C-159T polymorphism on nutritional status parameters in hemodialysis patients. Med Sci Monit. 2011;17:CR117–21. doi: 10.12659/MSM.881397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Stefano GB, Kream RM, Esch T. Revisiting tolerance from the endogenous morphine perspective. Med Sci Monit. 2009;15:RA189–98. [PubMed] [Google Scholar]
- 29.Vithoulkas G, Carlino S. The “continuum” of a unified theory of diseases. Med Sci Monit. 2010;16:SR7–15. [PubMed] [Google Scholar]
- 30.Weeks BS, Perez PP. The hemicellulose preparation, Natramune (PDS-2865), increases macrophage phagocytosis and nitric oxide production and increases circulating human lymphocytes levels. Med Sci Monit. 2009;15:BR43–6. [PubMed] [Google Scholar]
- 31.Romanowska M, Banaszkiewicz A, Nowak I, Radzikowski A, Brydak LB. Immunization against influenza during the 2005/2006 epidemic season and the humoral response in children with diagnosed inflammatory bowel disease (IBD) Med Sci Monit. 2010;16:CR433–9. [PubMed] [Google Scholar]
- 32.Gong YB, Huang YF, Li Y, et al. Experimental study of the mechanism of tolerance induction in dexamethasone-treated dendritic cells. Med Sci Monit. 2011;17:BR125–31. doi: 10.12659/MSM.881758. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Kubisz P, Plamenova I, Holly P, Stasko J. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy. Med Sci Monit. 2009;15:CS105–11. [PubMed] [Google Scholar]
- 34.Hossny E, El-Awady H, El-Feky M, El-Owaidy R. Screening for B- and T-cell defects in Egyptian infants and children with suspected primary immunodeficiency. Med Sci Monit. 2009;15:CR217–25. [PubMed] [Google Scholar]
- 35.Lu JM, Nurko J, Weakley SM, et al. Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update. Med Sci Monit. 2010;16:RA93–100. [PMC free article] [PubMed] [Google Scholar]
- 36.Ge P, Zhang P, Wang H, Zhong Y, Luo Y. Ischemic post-conditioning: a feasible preventive method for cerebral hyperperfusion syndrome secondary to revascularization. Med Sci Monit. 2010;16:SC9–11. [PubMed] [Google Scholar]
- 37.Rafael H. Revascularization in some neurodegenerative diseases. Med Sci Monit. 2009;15:LE5–6. [PubMed] [Google Scholar]
- 38.Park DH, Eve DJ, Borlongan CV, Klasko SK, Cruz LE, Sanberg PR. From the basics to application of cell therapy, a steppingstone to the conquest of neurodegeneration: a meeting report. Med Sci Monit. 2009;15:RA23–31. [PubMed] [Google Scholar]
- 39.Rafael H. Cerebral atherosclerosis causes neurodegenerative diseases. Med Sci Monit. 2010;16:LE1–2. [PubMed] [Google Scholar]
- 40.Alberti E, Los M, Garcia R, et al. Prolonged survival and expression of neural markers by bone marrow-derived stem cells transplanted into brain lesions. Med Sci Monit. 2009;15:BR47–54. [PubMed] [Google Scholar]
- 41.Gross S, Homan van der Heide JJ, van Son WJ, et al. Body mass index and creatinine clearance are associated with steady-state serum concentrations of the cell damage marker S100B in renal transplant recipients. Med Sci Monit. 2010;16:CR318–24. [PubMed] [Google Scholar]
- 42.Brucknerova I, Behulova D, Bzduch V, Mach M, Dubovicky M, Ujhazy E. Newborn with neonatal form of molybdenum cofactor deficiency – the first patient in the Slovak Republic. Neuro Endocrinol Lett. 2010;31(Suppl 2):5–7. [PubMed] [Google Scholar]
- 43.Bik W, Ostrowski J, Baranowska-Bik A, et al. Adipokines and genetic factors in overweight or obese but metabolically healthy Polish women. Neuro Endocrinol Lett. 2010;31:497–506. [PubMed] [Google Scholar]
- 44.Bik W, Baranowska B. Adiponectin – a predictor of higher mortality in cardiovascular disease or a factor contributing to longer life? Neuro Endocrinol Lett. 2009;30:180–4. [PubMed] [Google Scholar]
- 45.Chmielowska M, Baranowska-Bik A, Baranowska B, Wolinska-Witort E, Martynska L, Bik W. The influence of cocaine-amphetamine regulated transcript (CART) on pituitary hormones, corticosterone and leptin levels in starved rats. Neuro Endocrinol Lett. 2011;32:82–9. [PubMed] [Google Scholar]
- 46.Erren TC, Falaturi P, Reiter RJ. Research into the chronodisruption-cancer theory: the imperative for causal clarification and the danger of causal reductionism. Neuro Endocrinol Lett. 2010;31:1–3. [PubMed] [Google Scholar]
- 47.Kochman K, Gajewska A, Bieniarz K. Differential binding of mammalian and salmon GnRHs with rat and carp pituitary receptors. Neuro Endocrinol Lett. 2009;30:139–43. [PubMed] [Google Scholar]
- 48.Pisarek H, Kunert-Radek J, Radek M, Swietoslawski J, Winczyk K, Pawlikowski M. Expression of somatostatin receptor subtypes in primary and recurrent gonadotropinomas: are somatostatin receptors involved in pituitary adenoma recurrence? Neuro Endocrinol Lett. 2011;32:96–101. [PubMed] [Google Scholar]
- 49.Wasilewska-Dziubinska E, Gajewska A, Wolinska-Witort E, et al. Valproate inhibits GnRH-induced gonadotropin release from anterior pituitary cells of male rat in vitro. Neuro Endocrinol Lett. 2011;32:206–11. [PubMed] [Google Scholar]
- 50.Winczyk K, Kunert-Radek J, Gruszka A, Radek M, Lawnicka H, Pawlikowski M. Effects of rosiglitazone: peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro. Neuro Endocrinol Lett. 2009;30:107–10. [PubMed] [Google Scholar]
- 51.Ondicova K, Pecenak J, Mravec B. The role of the vagus nerve in depression. Neuro Endocrinol Lett. 2010;31:602–8. [PubMed] [Google Scholar]
- 52.Maes M, Kubera M, Obuchowiczwa E, Goehler L, Brzeszcz J. Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative and nitrosative stress pathways. Neuro Endocrinol Lett. 2011;32:7–24. [PubMed] [Google Scholar]
- 53.Erren TC, Reiter RJ. Axelrod, the pineal and the melatonin hypothesis: lessons of 50 years to shape chronodisruption research. Neuro Endocrinol Lett. 2010;31:585–7. [PubMed] [Google Scholar]
- 54.Kelemenova S, Ostatnikova D. Neuroendocrine pathways altered in autism. Special role of reelin. Neuro Endocrinol Lett. 2009;30:429–36. [PubMed] [Google Scholar]
- 55.Sieroslawska A, Rymuszka A. Cyanohepatotoxins influence on the neuroendocrine and immune systems in fish – a short review. Neuro Endocrinol Lett. 2009;30(Suppl 1):13–6. [PubMed] [Google Scholar]
